BR112018068941A2 - prevenção de adesão de tecidos biológicos - Google Patents

prevenção de adesão de tecidos biológicos

Info

Publication number
BR112018068941A2
BR112018068941A2 BR112018068941-6A BR112018068941A BR112018068941A2 BR 112018068941 A2 BR112018068941 A2 BR 112018068941A2 BR 112018068941 A BR112018068941 A BR 112018068941A BR 112018068941 A2 BR112018068941 A2 BR 112018068941A2
Authority
BR
Brazil
Prior art keywords
biological tissue
prevention
self
tissue adhesion
amino acids
Prior art date
Application number
BR112018068941-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Kobayashi Satoru
Original Assignee
3-D Matrix, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3-D Matrix, Ltd. filed Critical 3-D Matrix, Ltd.
Publication of BR112018068941A2 publication Critical patent/BR112018068941A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/043Proteins; Polypeptides; Degradation products thereof
    • A61L31/047Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/043Proteins; Polypeptides; Degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00818Treatment of the gastro-intestinal system
    • A61B2017/00823Appendectomy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B2017/00831Material properties
    • A61B2017/00893Material properties pharmaceutically effective

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
BR112018068941-6A 2016-03-18 2017-03-17 prevenção de adesão de tecidos biológicos BR112018068941A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662310121P 2016-03-18 2016-03-18
US201662310131P 2016-03-18 2016-03-18
US62/310,121 2016-03-18
US62/310,131 2016-03-18
PCT/IB2017/000312 WO2017158420A1 (en) 2016-03-18 2017-03-17 Preventing biological tissue adhesion

Publications (1)

Publication Number Publication Date
BR112018068941A2 true BR112018068941A2 (pt) 2019-04-16

Family

ID=58645327

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018068941-6A BR112018068941A2 (pt) 2016-03-18 2017-03-17 prevenção de adesão de tecidos biológicos

Country Status (11)

Country Link
US (4) US20190091376A1 (enExample)
EP (1) EP3429653B1 (enExample)
JP (1) JP7049557B2 (enExample)
KR (1) KR20190022455A (enExample)
CN (1) CN109152868A (enExample)
AU (2) AU2017232540A1 (enExample)
BR (1) BR112018068941A2 (enExample)
CA (1) CA3017684A1 (enExample)
CL (1) CL2018002646A1 (enExample)
MX (1) MX2018011121A (enExample)
WO (1) WO2017158420A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190022455A (ko) 2016-03-18 2019-03-06 가부시끼가이샤 쓰리디 매트릭스 생물학적 조직 유착을 방지하는 방법
JP7442196B2 (ja) 2018-07-03 2024-03-04 株式会社スリー・ディー・マトリックス イオン性自己組織化ペプチド
EP4125995A4 (en) 2020-03-31 2024-04-10 3-D Matrix, Ltd. STERILIZATION OF SELF-ASSEMBLY PEPTIDES BY IRRADIATION
KR20250155730A (ko) * 2024-04-24 2025-10-31 경희대학교 산학협력단 하지정맥 수술시 정맥 내벽의 기계 화학적 절제장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4049671A1 (en) 2004-07-06 2022-08-31 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
AU2006241123B2 (en) * 2005-04-25 2013-10-03 Massachusetts Institute Of Technology Compositions and methods for promoting hemostasis and other physiological activities
BRPI0920030B1 (pt) * 2008-10-06 2019-03-26 3-D Matrix, Ltd. Agente de oclusão do tecido, agentes hemostáticos, preventivos e de oclusão ou escleroterapia relacionados, e infusão do tecido mucosal
ES2653667T3 (es) * 2011-09-02 2018-02-08 3-D Matrix, Ltd. Péptidos anfifílicos para la oclusión del escape de aire torácico
US20160287744A1 (en) * 2012-11-14 2016-10-06 3-D Matrix Ltd. Vascular embolic system
EP2968654A1 (en) * 2013-03-14 2016-01-20 3-D Matrix, Ltd Treatment for bile leakage
US20210023257A1 (en) 2016-03-18 2021-01-28 3-D Matrix, Ltd. Cerebrospinal fluid leakage occlusion
EP3429646A1 (en) 2016-03-18 2019-01-23 3-D Matrix, Ltd Pancreatic fistula occlusion
KR20190022455A (ko) 2016-03-18 2019-03-06 가부시끼가이샤 쓰리디 매트릭스 생물학적 조직 유착을 방지하는 방법

Also Published As

Publication number Publication date
MX2018011121A (es) 2019-01-31
US12377196B2 (en) 2025-08-05
AU2017232540A1 (en) 2018-09-27
EP3429653B1 (en) 2022-11-09
AU2021225225A1 (en) 2021-09-30
US20220111126A1 (en) 2022-04-14
JP7049557B2 (ja) 2022-04-07
US20190091376A1 (en) 2019-03-28
EP3429653A1 (en) 2019-01-23
JP2019508184A (ja) 2019-03-28
CL2018002646A1 (es) 2019-07-05
US20230241294A1 (en) 2023-08-03
WO2017158420A1 (en) 2017-09-21
CA3017684A1 (en) 2017-09-21
CN109152868A (zh) 2019-01-04
KR20190022455A (ko) 2019-03-06
US20250177614A1 (en) 2025-06-05

Similar Documents

Publication Publication Date Title
PH12019501414A1 (en) Amino acid compositions and methods for the treatment of liver diseases
DOP2017000272A (es) Métodos de diagnóstico para tratamiento con linfocitos t
BR112018068838A2 (pt) oclusão de fístula pancreática
BR112018068941A2 (pt) prevenção de adesão de tecidos biológicos
BR112015006828A2 (pt) composto, ou um sal farmaceuticamente aceitável do mesmo; composição farmacêutica; método para tratar uma doença em um paciente em necessidade do tratamento; e método para modular a atividade de uma proteína ire1
PE20170140A1 (es) Metodos para tratar el cancer con inhibidores de tigit y agentes contra el cancer
WO2017163132A3 (en) Use of umbilical cord blood derived exosomes for tissue repair
PE20200748A1 (es) Composiciones de aminoacidos para el tratamiento de lesion neuronal
PH12020500321A1 (en) Amino acid compositions for the treatment of liver disease
BR112015028692A8 (pt) agente preventivo ou terapêutico para mastite de animal ruminante
BR112018005905A2 (pt) ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto?
HK1220413A1 (zh) 预防胃肠梗阻的材料
EP4553065A3 (en) Novel compounds for treating mitochondrial disease
MX2016016832A (es) Materiales y metodos para llenar cavidades oseas.
HK1220145A1 (zh) 胆漏治疗
EP3501532A3 (en) Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
WO2018108991A3 (en) Methods of treating amyloid-beta peptide diseases
MX2019005979A (es) Peptidos modificados.
CO2019009000A2 (es) Combinaciones farmacéuticas para tratar cáncer
MX2019006444A (es) Métodos de tratamiento de artropatía hemofílica utilizando factores de coagulación quiméricos.
BR112016023519A2 (pt) inibidor de sinalização de wnt/ß-catenina, composição farmacêutica e método de tratamento e/ou prevenção de uma patologia definida por malformação vascular
MX389589B (es) Dexmedetomidina o medetomidina para uso en el tratamiento de la ansiedad por separacion en perros.
ES2421407T3 (es) Agente y composición para la curación de heridas
MX2018011082A (es) Péptido o aminoácido n-lipoico, derivados y sus usos.
BR112018068939A2 (pt) oclusão de vazamento de fluido cérebro-espinhal

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements